|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/08 | (2019.01) |
| A61K 38/08 | (2013.01) | ||
| A61K 9/00 | (2006.01) | ||
| A61K 38/10 | (2013.01) | ||
| A61P 25/08 | (2006.01) | ||
| A61P 25/08 | (2018.01) |
| (11) | Patento numeris | 3527217 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17859632.6 |
| Europos patento paraiškos padavimo data | 2017-10-11 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-08-21 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2022-02-16 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/BR2017/050313 |
| Data | 2017-10-11 |
| (87) | Numeris | WO 2018/068119 |
| Data | 2018-04-19 |
| (30) | Numeris | Data | Šalis |
| 102016023848 | 2016-10-13 | BR |
| (72) |
REMER, Ricardo Amaral , BR
HEIMANN, Andrea Sterman , BR
|
| (73) |
Proteimax Biotecnologia Ltda ,
Av. Corifeu de Azevedo Marques 1425-Sala 6
Butantã, 05581001 São Paulo,
BR
Remer Consultores Assessoria Empresarial Ltda. , Rua Padre João Manuel 755 - 9ª andar, 01411-001 São Paulo, BR |
| (54) | PHARMACEUTICAL COMPOSITIONS COMPRISING PVNFKFLSH OR PVNFKLLSH PEPTIDES FOR USE IN THE PREVENTION AND TREATMENT OF CONVULSIONS |
| PHARMACEUTICAL COMPOSITIONS COMPRISING PVNFKFLSH OR PVNFKLLSH PEPTIDES FOR USE IN THE PREVENTION AND TREATMENT OF CONVULSIONS |